Education
About Us
Working with TipRanks
Follow Us
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 5.45B | ¥ 7.16B | ¥ 6.37B | ¥ 5.33B | ¥ 4.62B |
| Gross Profit | ¥ 1.80B | ¥ 2.33B | ¥ 2.03B | ¥ 2.09B | ¥ 1.73B |
| Operating Income | ¥ -238.11M | ¥ 1.14B | ¥ 773.20M | ¥ 1.33B | ¥ 1.31B |
| EBITDA | - | ¥ 1.37B | ¥ 726.64M | ¥ 1.88B | ¥ 1.83B |
| Net Income | - | ¥ 727.43M | ¥ 240.79M | ¥ 1.02B | ¥ 1.06B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.27B | ¥ 3.45B | ¥ 3.93B | ¥ 3.54B | ¥ 1.39B |
| Total Assets | ¥ 19.20B | ¥ 20.81B | ¥ 19.11B | ¥ 19.03B | ¥ 15.24B |
| Total Debt | ¥ 3.78B | ¥ 6.46B | ¥ 5.65B | ¥ 5.65B | ¥ 6.30B |
| Net Debt | ¥ 1.93B | ¥ 4.33B | ¥ 2.71B | ¥ 2.93B | ¥ 5.02B |
| Total Liabilities | ¥ 7.22B | ¥ 8.41B | ¥ 7.58B | ¥ 7.34B | ¥ 7.77B |
| Stockholders' Equity | ¥ 11.91B | ¥ 12.31B | ¥ 11.41B | ¥ 11.57B | ¥ 7.35B |
| Cash Flow | |||||
| Free Cash Flow | - | - | - | - | - |
| Operating Cash Flow | ¥ 398.22M | - | - | ¥ 37.28M | - |
| Investing Cash Flow | ¥ 1.22B | ¥ 249.84M | ¥ 719.93M | - | ¥ 1.70M |
| Financing Cash Flow | - | ¥ 329.56M | - | ¥ 2.51B | - |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Earnings and Revenue History
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.